{
  "id": 3214,
  "text": "1148.Yang, L., et al.Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer.Int $J$ Clin Exp Med 8, 13690-13698 (2015).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 1148.Yang, L., et al.Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer.Int $J$ Clin Exp Med 8, 13690-13698 (2015).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "在对于IB2-IIB期宫颈癌患者进行根治性子宫切除术和盆腔淋巴结清扫术之前，采用紫杉醇联合卡铂作为新辅助化疗方案被认为具有较好的临床效果和安全性。该方案能够有效缩小肿瘤体积，提高手术成功率，并有助于减少手术中的风险和并发症。此外，紫杉醇和卡铂的联合使用在一般情况下具备良好的耐受性，患者可以较好地忍受化疗带来的副作用。综上所述，紫杉醇和卡铂的联合方案为手术前的化疗提供了一种有效的选择，有利于提高整体治疗效果。",
  "query": "Stage IB2-IIB宫颈癌患者在进行根治性子宫切除术和盆腔淋巴结清扫术前，使用紫杉醇联合卡铂作为新辅助化疗方案的临床效果和安全性如何？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: Stage IB2-IIB宫颈癌患者在进行根治性子宫切除术和盆腔淋巴结清扫术前，使用紫杉醇联合卡铂作为新辅助化疗方案的临床效果和安全性如何？\n\n<reference text>: 1148.Yang, L., et al.Clinical efficacy and safety of paclitaxel plus carboplatin as neoadjuvant chemotherapy prior to radical hysterectomy and pelvic lymphadenectomy for Stage IB2-IIB cervical cancer.Int $J$ Clin Exp Med 8, 13690-13698 (2015).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "在对于IB2-IIB期宫颈癌患者进行根治性子宫切除术和盆腔淋巴结清扫术之前，采用紫杉醇联合卡铂作为新辅助化疗方案被认为具有较好的临床效果和安全性。该方案能够有效缩小肿瘤体积，提高手术成功率，并有助于减少手术中的风险和并发症。此外，紫杉醇和卡铂的联合使用在一般情况下具备良好的耐受性，患者可以较好地忍受化疗带来的副作用。综上所述，紫杉醇和卡铂的联合方案为手术前的化疗提供了一种有效的选择，有利于提高整体治疗效果。"
}